It separates the current label and checkout record from seller positioning and strain-specific probiotic research. Research involving another strain, dose, delivery format or patient group is not treated as proof of the finished ProDentim formula.
Verified product snapshot
The reviewed directions allow one tablet once or up to twice daily, ideally after oral care.
The count applies to the three-species probiotic blend as a whole—not to each species separately.
The label gives a 20 mg blend total but not the amount of each included probiotic.
This was displayed in the seller and ClickBank materials reviewed for our article.
Product materials reviewed
Formula facts from the reviewed label
| Declared component | Amount | What the label supports | Important boundary |
|---|---|---|---|
| Inulin | 100 mg | Presence and quantity in one serving. | The label does not establish the effect of this amount on oral health. |
| Probiotic blend | 20 mg; 3.5 billion CFU at manufacture | A combined blend containing Lactobacillus paracasei, Lactobacillus reuteri and Bifidobacterium lactis BL-04®. | The amount and CFU contribution of each organism are not disclosed separately. |
| Streptococcus salivarius | 20 mg | Presence and mass in one serving. | The reviewed label does not identify a K12, M18 or other strain designation or a CFU count. |
| Directions | 1 tablet once or up to twice daily | The tablet is intended to dissolve in the mouth, preferably after brushing or mouthwash. | The label directions should control over simplified instructions on promotional pages. |
Offer and checkout record
$158 product total plus $9.99 shipping in the reviewed checkout.
$207 product total with free shipping in the reviewed offer.
$294 product total with free shipping and three digital ebooks in the reviewed offer.
The current transaction terms should be confirmed again before payment.
The seller funnel reviewed for this dossier is accessed through an affiliate link. Pro Review Metric may earn a commission if a qualifying purchase is completed, at no additional cost to the buyer.
Open the current ProDentim offerSource map
ProDentim Supplement Facts panel
Supports: serving size, inulin amount, probiotic-blend mass, declared CFU at manufacture, listed organisms and separately listed Streptococcus salivarius.
Does not prove: clinical effectiveness, viable count at the time of use or the dose contributed by each organism.
View the label imageCurrent seller funnel and ClickBank checkout
Supports: package totals, visible shipping, digital bonuses, billing structure and the displayed 60-day policy.
Does not prove: product effectiveness or that prices and terms will remain unchanged.
Open the current offerClickBank customer refund instructions
Supports: the general process for locating a ClickBank order and submitting a refund request.
Does not prove: the product-specific refund period. That period must be confirmed in the current ProDentim transaction terms.
Read ClickBank refund instructionsIFF HOWARU® Bifidobacterium lactis Bl-04® information
Supports: Bl-04® is an identified Bifidobacterium lactis strain with commercial documentation centered on stability and immune or respiratory applications.
Important limit: this source does not establish an oral-health effect for the finished ProDentim tablet.
View IFF Bl-04® informationLactobacillus reuteri pilot randomized oral-health trial
Supports: specific L. reuteri strains DSM 17938 and ATCC PTA 5289 have been studied in a small randomized trial measuring oral-health indices in adolescents.
Important limits: only 27 participants were included, the study used identified strains and a defined tablet protocol, and the ProDentim label does not state that its L. reuteri is either study strain.
View the PubMed recordLactobacillus paracasei SD1 randomized trial
Supports: the SD1 strain of L. paracasei was studied in a randomized placebo-controlled trial involving salivary microorganisms in 40 healthy young adults.
Important limits: the intervention used milk powder, not a dissolving tablet, and ProDentim does not identify its L. paracasei as SD1.
View the PubMed recordStreptococcus salivarius K12 pilot randomized trial
Supports: S. salivarius K12 lozenges have been studied in a small double-blind, placebo-controlled pilot trial measuring salivary IgA, salivation and oral biofilm.
Important limits: the trial included 31 participants, and the reviewed ProDentim label lists S. salivarius without identifying the K12 strain or a CFU amount.
View the PubMed recordBifidobacterium lactis HN019 randomized gingivitis trial
Supports: a different B. lactis strain, HN019, has been evaluated as an adjunct to professional therapy in a randomized controlled gingivitis trial.
Important limits: HN019 is not Bl-04®, and a study of one B. lactis strain cannot be transferred automatically to another strain or to the complete ProDentim formula.
View the PubMed recordNo finished-product clinical trial was identified in the source set reviewed
The research located for this dossier concerns the product label, checkout and selected strain-specific studies. Because probiotic effects can be strain-, dose- and format-specific, those studies are not treated as clinical proof of ProDentim.
Evidence boundaries and unresolved questions
- The label does not disclose the individual amount or CFU contribution of L. paracasei, L. reuteri or B. lactis Bl-04®.
- The label lists CFU at manufacture, not a separately stated guaranteed count through the end of shelf life.
- The strain designation for L. paracasei, L. reuteri and Streptococcus salivarius is not shown on the reviewed panel.
- Strain-specific research cannot be transferred automatically to an unidentified strain or mixed finished product.
- No certificate of analysis or independent batch-testing report was included in the source set reviewed.
- Pro Review Metric has not documented firsthand use or physical inspection of the finished product in this dossier.
- The product is not a replacement for brushing, flossing, dental examinations or treatment of a diagnosed condition.
How this dossier was prepared
The Pro Review Metric Editorial Team compared the reviewed Supplement Facts panel, directions, package presentation and ClickBank checkout with strain-manufacturer documentation and selected randomized clinical-trial records.
External studies were used only to explain the research context of a named organism or strain. They were not presented as proof that ProDentim will produce the same result, particularly where the label does not disclose the studied strain, individual dose or CFU contribution.
See the Methodology, Editorial Policy, Editorial Team, Affiliate Disclosure and Medical Disclaimer pages for the standards governing source selection, authorship, AI assistance, affiliate relationships, health-content boundaries and corrections.
Update history
Dossier created. Label facts, package totals, checkout terms and strain-specific research boundaries mapped for publication.
Affiliate links migrated to the PRM /go/ tracking layer and editorial-policy links aligned with the current site architecture. No product-fact or evidence conclusion was changed.